https://ir.corbuspharma.com/sec-filings/annual-reports/rss Corbus Pharmaceuticals Holdings, Inc. (CRBP) - Annual Reports en-us https://d1io3yog0oux5.cloudfront.net/_dc5231ac157b9ee4fb322b64fcb7a082/corbuspharma/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140398/0001193125-26-140398.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140398/0001193125-26-140398.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-098530/0001193125-26-098530.pdf Mon, 09 Mar 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-098530/0001193125-26-098530.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-048613/0000950170-25-048613.pdf Tue, 01 Apr 25 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-048613/0000950170-25-048613.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-037335/0000950170-25-037335.pdf Tue, 11 Mar 25 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-037335/0000950170-25-037335.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-040250/0000950170-24-040250.pdf Tue, 02 Apr 24 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-040250/0000950170-24-040250.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-034266/0000950170-24-034266.pdf Wed, 20 Mar 24 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-034266/0000950170-24-034266.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-030133/0000950170-24-030133.pdf Tue, 12 Mar 24 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-030133/0000950170-24-030133.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-011609/0000950170-23-011609.pdf Mon, 03 Apr 23 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-011609/0000950170-23-011609.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-006469/0000950170-23-006469.pdf Tue, 07 Mar 23 00:00:00 -0500 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-006469/0000950170-23-006469.pdf https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-22-003145/0000950170-22-003145.pdf Tue, 08 Mar 22 00:00:00 -0500 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-22-003145/0000950170-22-003145.pdf